Weill David's Form 4 filing
TransMedics Group, Inc. (TMDX) · filed May 23, 2025
- Accession no.
- 0000950170-25-077211
- Filed
- May 23, 2025
- Trade date
- May 22-23, 2025
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $90.7K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Weill DavidCIK 0001774270 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 22, 2025 | Common Stock | AGrant or awardAcquired | +2,134 | $0.00 | $0 | 12,866 | Direct | |
| May 23, 2025 | Common Stock | SSaleDisposed | −732 | $123.88 | −$90,680.16 | 12,134 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.